Fang JY, Lu YY: Effects of histone acetylation and DNA methylation on p21(WAF1) regulation. World J Gastroenterol. 2002, 8: 400-405.
CAS
PubMed
Google Scholar
Kumar P, Xi Y: MicroRNA, epigenetic machinery and lung cancer. Thoracic Cancer. 2011, 2: 35-44. 10.1111/j.1759-7714.2011.00043.x.
Article
Google Scholar
Kimura N, Nagasaka T, Murakami J, Sasamoto H, Murakami M, Tanaka N, Matsubara N: Methylation profiles of genes utilizing newly developed CpG island methylation microarray on colorectal cancer patients. Nucleic Acids Res. 2005, 33: e46-10.1093/nar/gni046.
Article
PubMed Central
PubMed
Google Scholar
Lee S, Hwang KS, Lee HJ, Kim JS, Kang GH: Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest. 2004, 84: 884-893. 10.1038/labinvest.3700108.
Article
CAS
PubMed
Google Scholar
Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS: Aberrant CpG island hyperme- thylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol. 2003, 163: 1551-1556. 10.1016/S0002-9440(10)63511-0.
Article
PubMed Central
CAS
PubMed
Google Scholar
Oue N, Matsumura S, Nakayama H, Kitadai Y, Taniyama K, Matsusaki K, Yasui W: Reduced expression of the TSP1 gene and its association with promoter hypermethylation in gastric carcinoma. Oncology. 2003, 64: 423-429. 10.1159/000070302.
Article
CAS
PubMed
Google Scholar
Xue WC, Chan KY, Feng HC, Chiu PM, Ngan HY, Tsao SW, Cheung AN: Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. Mol Diagn. 2004, 6: 326-334. 10.1016/S1525-1578(10)60528-4.
Article
CAS
Google Scholar
Kim H, Kim YH, Kim SE, Kim NG, Noh SH, Kim H: Concerted promoter hypermethy- lation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. J Pathol. 2003, 200: 23-31. 10.1002/path.1325.
Article
CAS
PubMed
Google Scholar
Lindsey JC, Lusher ME, Anderton JA, Bailey S, Gilbertson RJ, Pearson AD, Ellison DW, Clifford SC: Identification of tumour-specific epigenetic events in medullo- blastoma development by hypermethylation profiling. Carcinogenesis. 2004, 25: 661-668.
Article
CAS
PubMed
Google Scholar
Sobin LH, Fleming ID: TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer Cancer. 1997, 80 (9): 1803-1804.
CAS
PubMed
Google Scholar
Liu X, Xiong H, Li J, He Y, Yuan X: Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancer. Diagn Pathol. 2013, 8: 62-10.1186/1746-1596-8-62.
Article
PubMed Central
PubMed
Google Scholar
Dong X, Wang G, Zhang G, Ni Z, Suo J, Cui J, et al.: The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer. Diagn Pathol. 2013, 8: 45-10.1186/1746-1596-8-45.
Article
PubMed Central
CAS
PubMed
Google Scholar
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: A novel PCR assay for methylation status of CpG island. Proc Natl Acad Sci USA. 1996, 93: 9821-9826. 10.1073/pnas.93.18.9821.
Article
PubMed Central
CAS
PubMed
Google Scholar
Shimizu M, Saitoh Y, Itoh H: Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissue. Hum Pathol. 1990, 21: 607-612. 10.1016/S0046-8177(96)90006-4.
Article
CAS
PubMed
Google Scholar
Vogelauer M, Wu J, Suka N, Grunstein M: Global histone acetylation and deacetylation in yeast. Nature. 2000, 408: 495-498. 10.1038/35044127.
Article
CAS
PubMed
Google Scholar
Sadiq A, Mansour KA: Esophageal cancer: recent advances. Thoracic Cancer. 2011, 2: 75-83. 10.1111/j.1759-7714.2011.00054.x.
Article
Google Scholar
Suter CM, Norrie M, Ku SL, Cheong KF, Tomlinson I, Ward RL: CpG island methylation is a common finding in colorectal cancer cell lines. Br J Cancer. 2003, 88 (3): 413-419. 10.1038/sj.bjc.6600699.
Article
PubMed Central
CAS
PubMed
Google Scholar
Baylin SB, Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000, 16: 168-174. 10.1016/S0168-9525(99)01971-X.
Article
CAS
PubMed
Google Scholar
Colot V, Maloisel L, Rossignol JL: DNA repeats and homologous recombination: a probable role for DNA methylation in genome stability of eukaryotic cells. J Soc Biol. 1999, 193: 29-34.
CAS
PubMed
Google Scholar
Kaneda A, Kaminishi M, Yanagihara K, Sugimura T, Ushijima T: Identification of silencing of nine genes in human gastric cancer. Cancer Res. 2002, 62: 6645-6650.
PubMed
Google Scholar
Leco KJ, Waterhouse P, Sanchez OH, Gowing KL, Poole AR, Wakeham A, Mak TW, Khokha R: Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest. 2001, 108: 817-829.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mannello F, Gazzanelli G: Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis. 2001, 6: 479-482. 10.1023/A:1012493808790.
Article
CAS
PubMed
Google Scholar
Smith MR, Kung H, Durum SK, Colburn NH, Sun Y: TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine. 1997, 9: 770-780. 10.1006/cyto.1997.0233.
Article
CAS
PubMed
Google Scholar
Gagnon J, Shaker S, Primeau M, Hurtubise A, Momparler RL: Interaction of 5-aza-2′- deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells. Anticancer Drugs. 2003, 14: 193-202. 10.1097/00001813-200303000-00002.
Article
CAS
PubMed
Google Scholar
Feng H, Cheung AN, Xue WC, Wang Y, Wang X, Fu S, Wang Q, Ngan HY, Tsao SW: Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma. Gynecol Oncol. 2004, 94: 375-382. 10.1016/j.ygyno.2004.04.019.
Article
CAS
PubMed
Google Scholar
Youn HG, An JY, Choi MG, Noh JH, Sohn TS, Kim S: Recurrence after curative resection of early gastric cancer. Ann Surg Oncol. 2010, 17: 448-454. 10.1245/s10434-009-0772-2.
Article
PubMed
Google Scholar
Jin J, Jin T, Quan M, Piao Y, Lin Z: Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma. Diagn Pathol. 2012, 7: 135-10.1186/1746-1596-7-135.
Article
PubMed Central
CAS
PubMed
Google Scholar
Fan LL, Chen DF, Lan CH, Liu KY, Fang DC: Knockdown of ezrin via RNA interference suppresses Helicobacter pylori-enhanced invasion of gastric cancer cells. Cancer Biol Ther. 2011, 11: 746-752. 10.4161/cbt.11.8.14691.
Article
CAS
PubMed
Google Scholar
Kerbel RS: Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv Cancer Res. 1990, 55: 87-131.
Article
CAS
PubMed
Google Scholar
Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, De Marzo AM, Isaacs WB, Nelson WG: Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res. 2004, 64: 1975-1986. 10.1158/0008-5472.CAN-03-3972.
Article
CAS
PubMed
Google Scholar
Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH: Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol. 2003, 163: 1371-1378. 10.1016/S0002-9440(10)63495-5.
Article
PubMed Central
CAS
PubMed
Google Scholar
Galm O, Rountree MR, Bachman KE, Jair KW, Baylin SB, Herman JG: Enzymatic regional methylation assay:a novel method quantify regional CpG methylation densuty. Genome Res. 2002, 12: 153-157. 10.1101/gr.202501.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kang GH, Lee S, Shim YH, Kim JC, Ro JY, Shim Y-H: Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability. Cancer Res. 2001, 61: 2847-2851.
CAS
PubMed
Google Scholar